Prostate Cancer Management Masterclass

Dr. Evan Y. Yu is a medical oncologist specializing in genitourinary malignancies, specifically prostate, bladder and testicular cancer treatment and research. His research focuses on testing the next wave of novel molecular targeted therapies and immunotherapy techniques, with a complementary focus on imaging biomarkers. He is Section Head, Medical Oncology in the Clinical Research Division at Fred Hutch Cancer Center. He also serves as the Medical Director for Clinical Research for the Fred Hutch/University of Washington/Seattle Children’s Cancer Consortium. He is a Professor at the University of Washington and Fred Hutch Cancer Center. He is principal investigator for the National Cancer Trials Network Lead Academic Performance Site (LAPS) Grant, SWOG, and ECOG/ACRIN. Dr. Yu is also the core director for the Pacific Northwest Prostate Cancer SPORE and co-PI of the DoD Prostate Cancer Clinical Trials Consortium for his institution. He graduated Alpha Omega Alpha from the University of Washington School of Medicine. Previously, he served as a Hematology/Oncology Fellowship Program Director for a decade at Fred Hutch. He has regularly been voted a “Top Doctor” by Castle Connolly, Seattle Magazine, and Seattle Met magazine. He has served for many years on the National Cancer Institute Genitourinary Cancers Steering Committee and is currently the co-chair for the National Cancer Institute Prostate Cancer Task Force. Dr. Yu has held various leadership/committee roles within ASCO, AACR, and also serves as a senior editor for Clinical Cancer Research and Uro-Today.

Following a residency at Mt. Sinai Hospital in New York City, Dr Dorff came to LAC + USC Medical Center for her hematology and medical oncology fellowship. She currently heads the Genitourinary group within the Department of Medical Oncology at the City of Hope Comprehensive Cancer Center. In addition to being a devoted clinician and translational researcher, Dr Dorff has authored more than 45 peer reviewed articles as well as 35 review articles/commentaries. Dr Dorff serves as an associate editor for Clinical Genitourinary Cancer and Seminars in Urologic Oncology. She has lectured on prostate and bladder cancer treatment nationally and internationally and has presented her research at national meetings. Current research interests include the effects of fasting on chemotherapy side effects and cancer control and immunotherapy for prostate cancer. She has been the principal investigator for more than a dozen clinical trials, involving targeted therapy and immunotherapy, for genitourinary cancers.